NVAX Company Profile and Key Details

Q: Who are the executives of NVAX?

Mr. Biegie LeeSenior Vice President & Chief Information OfficerMr. Troy Morgan Esq., J.D.Senior Vice President & Chief Compliance OfficerMs. Erika S. TrahanAssociate Director of Investor & PRMr. Stanley Charles ErckAdvisorMr. John A. Herrmann IIIExecutive Vice President, Chief Legal Officer & Corporation Sec.Mr. Richard P. CrowleyExecutive Vice President & Chief Operating OfficerDr. Gregory M. GlennPres of R&DDr. Gale E. SmithSenior Vice President of Discovery & Pre-Clinical Research and Chief ScientistDr. Gregory M. Glenn M.D.Pres of R&DMr. John A. Herrmann III, J.D.Executive Vice President & Chief Legal OfficerMr. John Joseph Trizzino B.S., M.B.A.Executive Vice President, Chief Commercial Officer & Chief Bus. OfficerDr. Filip Dubovsky FAAP, M.D., M.P.H.Pres of R&DMs. Jill Hoyt SPHRExecutive Vice President & Chief HR OfficerMs. Silvia Taylor M.B.A., MBAExecutive Vice President and Chief Corporation Affairs & Advocacy OfficerMr. James Patrick Kelly C.F.A.Executive Vice President, Chief Financial Officer & Treasurer

NASDAQ : NVAX

Novavax

$10.34

0.02+0.19%

At Close 4:00 PM

61.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Novavax, Inc. (NVAX) stock surged +0.19%, trading at $10.34 on NASDAQ, up from the previous close of $10.32. The stock opened at $10.42, fluctuating between $9.90 and $10.48 in the recent session.

Stock Snapshot

10.32

Prev. Close

1.7B

Market Cap

9.9001

Day Low

-6.8

P/E Ratio

-1.52

EPS (TTM)

-6.25

Cash Flow per Share

10.42

Open

164.44M

Number of Shares

10.48

Day High

84.18%

Free Float in %

-5.8

Book Value

6.21M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 03, 2026	10.42	10.48	9.90	10.34	5.21M
Sep 02, 2026	10.28	10.73	9.96	10.32	5.62M
Sep 01, 2026	9.20	10.26	9.19	10.12	10.02M
Aug 31, 2026	9.10	9.99	9.09	9.37	7.26M
Aug 28, 2026	9.18	9.34	8.89	9.26	4.2M
Aug 27, 2026	9.12	9.18	8.91	9.05	3.42M
Aug 26, 2026	9.33	9.44	9.13	9.21	3.51M
Aug 25, 2026	9.07	9.58	8.93	9.44	7.08M
Aug 24, 2026	8.87	8.98	8.26	8.86	5.56M
Aug 21, 2026	8.44	9.20	8.44	8.94	10.44M
Aug 20, 2026	8.50	8.66	8.02	8.42	5.97M
Aug 19, 2026	8.43	8.83	8.19	8.79	11.39M
Aug 18, 2026	7.97	8.08	7.84	7.93	2.01M
Aug 17, 2026	8.05	8.17	7.95	8.07	1.92M
Aug 14, 2026	8.13	8.13	7.92	8.05	2.27M
Aug 13, 2026	8.01	8.23	7.92	8.14	3.5M
Aug 12, 2026	7.91	7.99	7.83	7.96	2.52M
Aug 11, 2026	7.92	8.03	7.78	7.95	2.6M
Aug 10, 2026	7.89	7.96	7.70	7.89	3.21M
Aug 07, 2026	7.75	8.09	7.60	7.95	5.7M

Contact Details

Gaithersburg, MD 20878

United States

https://www.novavax.com 240 268 2000

About Company

Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.

Stock Peers

ARGX

-1.91-0.18%

argenx SE$1,053.46 REGN

-8.56-1.00%

Regeneron Pharmaceuticals, Inc.$843.47 VRTX

1.21+0.22%

Vertex Pharmaceuticals Incorporated$557.96 MDGL

-4.32-0.79%

Madrigal Pharmaceuticals, Inc.$542.61 UTHR

-1.78-0.36%

United Therapeutics Corporation$490.24 KRYS

2.24+0.61%

Krystal Biotech, Inc.$371.47 ONC

0.9+0.25%

BeOne Medicines AG$362.68 PRAX

-2.35-0.66%

Praxis Precision Medicines, Inc.$355.15 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

2.82+0.98%

Ligand Pharmaceuticals Incorporated$289.74

Frequently Asked Questions

What is the current Novavax, Inc. (NVAX) stock price?

Novavax, Inc. (NASDAQ: NVAX) stock price is $10.34 in the last trading session. During the trading session, NVAX stock reached the peak price of $10.48 while $9.90 was the lowest point it dropped to. The percentage change in NVAX stock occurred in the recent session was 0.19% while the dollar amount for the price change in NVAX stock was $0.02.

NVAX's industry and sector of operation?

The NASDAQ listed NVAX is part of Biotechnology industry that operates in the broader Healthcare sector. Novavax, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NVAX?

Mr. Biegie Lee
Senior Vice President & Chief Information Officer
Mr. Troy Morgan Esq., J.D.
Senior Vice President & Chief Compliance Officer
Ms. Erika S. Trahan
Associate Director of Investor & PR
Mr. Stanley Charles Erck
Advisor
Mr. John A. Herrmann III
Executive Vice President, Chief Legal Officer & Corporation Sec.
Mr. Richard P. Crowley
Executive Vice President & Chief Operating Officer
Dr. Gregory M. Glenn
Pres of R&D
Dr. Gale E. Smith
Senior Vice President of Discovery & Pre-Clinical Research and Chief Scientist
Dr. Gregory M. Glenn M.D.
Pres of R&D
Mr. John A. Herrmann III, J.D.
Executive Vice President & Chief Legal Officer
Mr. John Joseph Trizzino B.S., M.B.A.
Executive Vice President, Chief Commercial Officer & Chief Bus. Officer
Dr. Filip Dubovsky FAAP, M.D., M.P.H.
Pres of R&D
Ms. Jill Hoyt SPHR
Executive Vice President & Chief HR Officer
Ms. Silvia Taylor M.B.A., MBA
Executive Vice President and Chief Corporation Affairs & Advocacy Officer
Mr. James Patrick Kelly C.F.A.
Executive Vice President, Chief Financial Officer & Treasurer

How NVAX did perform over past 52-week?

NVAX's closing price is 66.77% higher than its 52-week low of $6.20 where as its distance from 52-week high of $11.97 is -13.62%.

How many employees does NVAX have?

Number of NVAX employees currently stands at 749.

Link for NVAX official website?

Official Website of NVAX is: https://www.novavax.com

How do I contact NVAX?

NVAX could be contacted at phone 240 268 2000 and can also be accessed through its website. NVAX operates from 21 Firstfield Road, Gaithersburg, MD 20878, United States.

How many shares of NVAX are traded daily?

NVAX stock volume for the day was 6.21M shares. The average number of NVAX shares traded daily for last 3 months was 4.25M.

What is the market cap of NVAX currently?

The market value of NVAX currently stands at $1.70B with its latest stock price at $10.34 and 164.44M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	749
Beta	2.42
Sales or Revenue	$983.71M
5Y Sales Change%	1.977%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	749
Beta	2.42
Sales or Revenue	$983.71M
5Y Sales Change%	1.977%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

NVAX Company Profile and Key Details

Novavax

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Valuation Metrics

Key Takeaways

Price Forecast & Outlook

Company Overview